FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3088800697> ?p ?o ?g. }

• W3088800697 endingPage "e299" @default.
• W3088800697 startingPage "e290" @default.
• W3088800697 abstract "Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) targets multiple organs and causes severe coagulopathy. Histopathological organ changes might not only be attributable to a direct virus-induced effect, but also the immune response. The aims of this study were to assess the duration of viral presence, identify the extent of inflammatory response, and investigate the underlying cause of coagulopathy.This prospective autopsy cohort study was done at Amsterdam University Medical Centers (UMC), the Netherlands. With informed consent from relatives, full body autopsy was done on 21 patients with COVID-19 for whom autopsy was requested between March 9 and May 18, 2020. In addition to histopathological evaluation of organ damage, the presence of SARS-CoV-2 nucleocapsid protein and the composition of the immune infiltrate and thrombi were assessed, and all were linked to disease course.Our cohort (n=21) included 16 (76%) men, and median age was 68 years (range 41-78). Median disease course (time from onset of symptoms to death) was 22 days (range 5-44 days). In 11 patients tested for SARS-CoV-2 tropism, SARS-CoV-2 infected cells were present in multiple organs, most abundantly in the lungs, but presence in the lungs became sporadic with increased disease course. Other SARS-CoV-2-positive organs included the upper respiratory tract, heart, kidneys, and gastrointestinal tract. In histological analyses of organs (sampled from nine to 21 patients per organ), an extensive inflammatory response was present in the lungs, heart, liver, kidneys, and brain. In the brain, extensive inflammation was seen in the olfactory bulbs and medulla oblongata. Thrombi and neutrophilic plugs were present in the lungs, heart, kidneys, liver, spleen, and brain and were most frequently observed late in the disease course (15 patients with thrombi, median disease course 22 days [5-44]; ten patients with neutrophilic plugs, 21 days [5-44]). Neutrophilic plugs were observed in two forms: solely composed of neutrophils with neutrophil extracellular traps (NETs), or as aggregates of NETs and platelets..In patients with lethal COVID-19, an extensive systemic inflammatory response was present, with a continued presence of neutrophils and NETs. However, SARS-CoV-2-infected cells were only sporadically present at late stages of COVID-19. This suggests a maladaptive immune response and substantiates the evidence for immunomodulation as a target in the treatment of severe COVID-19.Amsterdam UMC Corona Research Fund." @default.
• W3088800697 created "2020-10-01" @default.
• W3088800697 creator A5000576823 @default.
• W3088800697 creator A5002398450 @default.
• W3088800697 creator A5003751896 @default.
• W3088800697 creator A5009118630 @default.
• W3088800697 creator A5010959513 @default.
• W3088800697 creator A5011711816 @default.
• W3088800697 creator A5012963509 @default.
• W3088800697 creator A5024748941 @default.
• W3088800697 creator A5030595673 @default.
• W3088800697 creator A5032689562 @default.
• W3088800697 creator A5033745015 @default.
• W3088800697 creator A5034020165 @default.
• W3088800697 creator A5036345568 @default.
• W3088800697 creator A5040218841 @default.
• W3088800697 creator A5043416372 @default.
• W3088800697 creator A5044455625 @default.
• W3088800697 creator A5045590497 @default.
• W3088800697 creator A5047811685 @default.
• W3088800697 creator A5051612884 @default.
• W3088800697 creator A5051889611 @default.
• W3088800697 creator A5052380807 @default.
• W3088800697 creator A5055566178 @default.
• W3088800697 creator A5057667502 @default.
• W3088800697 creator A5060053979 @default.
• W3088800697 creator A5062180484 @default.
• W3088800697 creator A5073171672 @default.
• W3088800697 creator A5075604032 @default.
• W3088800697 creator A5083920266 @default.
• W3088800697 creator A5086022444 @default.
• W3088800697 creator A5086717130 @default.
• W3088800697 date "2020-11-01" @default.
• W3088800697 modified "2023-10-14" @default.
• W3088800697 title "Viral presence and immunopathology in patients with lethal COVID-19: a prospective autopsy cohort study" @default.
• W3088800697 cites W1975857445 @default.
• W3088800697 cites W20079332 @default.
• W3088800697 cites W2010917880 @default.
• W3088800697 cites W2030963238 @default.
• W3088800697 cites W2040991910 @default.
• W3088800697 cites W2045819100 @default.
• W3088800697 cites W2071039804 @default.
• W3088800697 cites W2162510519 @default.
• W3088800697 cites W2519468451 @default.
• W3088800697 cites W2523917817 @default.
• W3088800697 cites W2964477617 @default.
• W3088800697 cites W2972785413 @default.
• W3088800697 cites W3005949806 @default.
• W3088800697 cites W3007238890 @default.
• W3088800697 cites W3013219143 @default.
• W3088800697 cites W3014622337 @default.
• W3088800697 cites W3015539298 @default.
• W3088800697 cites W3016023990 @default.
• W3088800697 cites W3016393661 @default.
• W3088800697 cites W3017125154 @default.
• W3088800697 cites W3017129059 @default.
• W3088800697 cites W3018517500 @default.
• W3088800697 cites W3020909574 @default.
• W3088800697 cites W3021862213 @default.
• W3088800697 cites W3024126428 @default.
• W3088800697 cites W3024268458 @default.
• W3088800697 cites W3026167669 @default.
• W3088800697 cites W3027918021 @default.
• W3088800697 cites W3028448736 @default.
• W3088800697 cites W3031456278 @default.
• W3088800697 cites W3033997257 @default.
• W3088800697 cites W3034032308 @default.
• W3088800697 cites W3035063822 @default.
• W3088800697 cites W3045195423 @default.
• W3088800697 cites W3045277594 @default.
• W3088800697 cites W3126061642 @default.
• W3088800697 cites W4210642183 @default.
• W3088800697 doi "https://doi.org/10.1016/s2666-5247(20)30144-0" @default.
• W3088800697 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7518879" @default.
• W3088800697 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33015653" @default.
• W3088800697 hasPublicationYear "2020" @default.
• W3088800697 type Work @default.
• W3088800697 sameAs 3088800697 @default.
• W3088800697 citedByCount "393" @default.
• W3088800697 countsByYear W30888006972020 @default.
• W3088800697 countsByYear W30888006972021 @default.
• W3088800697 countsByYear W30888006972022 @default.
• W3088800697 countsByYear W30888006972023 @default.
• W3088800697 crossrefType "journal-article" @default.
• W3088800697 hasAuthorship W3088800697A5000576823 @default.
• W3088800697 hasAuthorship W3088800697A5002398450 @default.
• W3088800697 hasAuthorship W3088800697A5003751896 @default.
• W3088800697 hasAuthorship W3088800697A5009118630 @default.
• W3088800697 hasAuthorship W3088800697A5010959513 @default.
• W3088800697 hasAuthorship W3088800697A5011711816 @default.
• W3088800697 hasAuthorship W3088800697A5012963509 @default.
• W3088800697 hasAuthorship W3088800697A5024748941 @default.
• W3088800697 hasAuthorship W3088800697A5030595673 @default.
• W3088800697 hasAuthorship W3088800697A5032689562 @default.
• W3088800697 hasAuthorship W3088800697A5033745015 @default.
• W3088800697 hasAuthorship W3088800697A5034020165 @default.
• W3088800697 hasAuthorship W3088800697A5036345568 @default.
• W3088800697 hasAuthorship W3088800697A5040218841 @default.

• next